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Introduction
In the last few years the landscape has
changed dramatically for policymakers
seeking to use research evidence in the
policymaking process. The landscape has
also changed for the many stakeholders
seeking to use research evidence to
influence the policymaking process. The
task once seemed overwhelming given the
dearth of synthesized research evidence on
the ‘‘big’’, typically multifaceted, questions
that matter to policymakers and stake-
holders [1,2]. Now it isn’t uncommon for
these groups to find dozens of systematic
reviews that address the governance,
financial, and delivery arrangements with-
in health systems that can determine
whether a cost-effective program, service,
or drug reaches those who need it. For
example, teams of African policymakers,
stakeholders, and researchers drew on 30
reviews for what at first glance seems a
straightforward question: how to support
the widespread use of artemisinin-based
combination therapy (ACT) to treat un-
complicated falciparum malaria. The re-
view of qualitative studies of people’s views
about and experiences with medicine
sellers provided insights that were as
central to the process as reviews of the
effectiveness of a particular ACT formu-
lation or the home-based management of
malaria [3–5].
For policymakers and stakeholders the
challenge in using research evidence has
shifted from making the best possible use
of local studies to: (1) finding systematic
reviews that address their many questions
related to the policy issue at hand; (2)
deriving insights from the reviews for a
particular context (which may differ from
where the studies included in the review
were conducted); and (3) combining these
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Summary Points
N Policymakers need many types of research evidence—synthesized and
packaged for them—and the use of this evidence supported in multiple
complementary ways. Stakeholders who seek to influence the policymaking
process have the same requirements.
N Policymakers and stakeholders need many types of systematic reviews. For
example, reviews of qualitative studies can help to identify alternative framings
of the problem, to understand how or why a policy or program option works,
and to appreciate stakeholders’ perspectives on particular options.
N Policymakers and stakeholders now have access to many review-derived
products: (1) summaries of systematic reviews highlighting decision-relevant
information; (2) overviews of systematic reviews providing a ‘‘map’’ of the policy
questions addressed by systematic reviews and the insights derived from them;
and (3) policy briefs drawing on many systematic reviews to characterize a
problem, policy or program options to address the problem, and implemen-
tation strategies.
N A range of activities are being undertaken to support the use of reviews and
review-derived products in policymaking, all of which warrant rigorous
evaluation.
N Future challenges include: (1) examining whether and when any apparent
duplication of efforts occurs in the production of review-derived products at
the international level; and (2) scaling up activities that are found to be effective
in supporting the use of reviews and review-derived products in policymaking.
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and studies and from local tacit (‘‘how to’’)
knowledge and other forms of knowledge
[1,6–8]. Policymakers and stakeholders
then need many types of systematic
reviews, for these reviews to be packaged
in different ways in order to facilitate their
use in policymaking, and more generally
for their use of the reviews to be supported
in multiple complementary ways. The
same holds true for health system manag-
ers, including those working in hospitals,
nongovernmental organizations, and
many others settings. In some countries
these managers are counted as policy-
makers, and in others they are counted as
stakeholders. In all countries they are
decision makers in their own right. Much
of what follows applies to health system
managers as well.
Need for Many Types of
Reviews
Policymakers and stakeholders need
many types of reviews to inform any given
policymaking process (Table 1). For exam-
ple, reviews of observational studies can
help to establish the magnitude of the
problem (or the factors that contribute to
it),characterizetheharmsandkeyelements
of policy and program options for address-
ing the problem, and identify potential
barriers to implementing a preferred option
[9,10]. Reviews of qualitative studies can
help to identify alternative framings of the
problem, understand how or why a policy
or program option works (particularly if
local adaptation is being considered),
appreciate stakeholder’s views about and
experiences with particular options, and
identify potential barriers to implementing
a preferred option [11–13]. Reviews of
effectiveness studies can help to character-
ize the benefits and sometimes the harms of
each option being considered [14]. And
finally,reviewsof economic evaluations can
help to characterize the cost-effectiveness of
options [15]. Policymakers and stakehold-
ers can find increasing numbers of all of
these types of reviews.
Of course the insights derived from
these reviews must compete with many
other factors in the policymaking process,
such as institutional constraints, interest
group pressure, citizens’ values, and other
types of information like policymakers’
past experiences [16]. But some of these
types of reviews can provide helpful
ammunition in a fight over problem
definition or helpful background for a
discussion with stakeholders about a prob-
lem or about possible policy and program
options to address it. Moreover, the
strategic use of reviews during ‘‘windows
of opportunity’’ created by political events,
such as the election of a new government
or an interest group pressure campaign,
can help to push some problems or options
higher or lower on the agenda [17].
Systematic reviews can also be drawn
upon to develop a monitoring and evalu-
ation plan when there is substantial
uncertainty about what can be expected
from a policy or program.
Growing Availability of Review-
Derived Products
Policymakers and stakeholders now
have access to at least three types of
review-derived products: (1) summaries of
systematic reviews that highlight decision-
relevant information; (2) overviews of
systematic reviews that provide a ‘‘map’’
of what policy questions have been
addressed by systematic reviews and where
additional reviews are needed and that
derive insights from these reviews; and (3)
policy briefs that draw on many systematic
Table 1. Examples of the types of systematic reviews needed in different steps in the policymaking process.
Steps in a Policy-
making Process
Sub-Steps that Involve Acquiring Data and/or Research
Evidence
Examples of the Types of Systematic Reviews That
Can Be Acquired
Defining the problem Identifying indicators to establish the magnitude of the
problem (or the factors that contribute to it)
Reviews of observational studies (e.g., administrative database
studies, community surveys)
Making comparisons (over time, across settings or against plans) to
establish the magnitude of the problem (or the factors that
contribute to it)
Reviews of observational studies (e.g., administrative database
studies, community surveys)
Highlighting alternative framings of the problem to assist with
mobilizing support among different groups to address the
problem
Reviews of qualitative studies that examine stakeholders’ views
about and experiences with the problem (e.g., studies in which
narrative data are collected from individual or groups of
‘‘informants’’ through interviews, focus groups, participant
observation, or from documents)
Assessing potential
policy and program
options
Identifying policy and program options that could affect
the problem (or the factors that contribute to it)
(Frameworks embedded in) Reviews or overviews of systematic
reviews of any type if frameworks were used to organise the search
for, and presentation of, research evidence (as well as theories and
frameworks that are the focus of articles/reports in their own right)
Characterizing the positive effects (benefits) of each policy option Reviews of effectiveness studies (e.g., randomized controlled trials,
interrupted time series)
Characterizing the negative effects (harms) of each policy option Reviews of effectiveness and/or observational studies
Characterizing the cost-effectiveness of policy options Reviews of economic evaluations
Identifying the key elements of complex policy options (to
facilitate local adaptation if necessary)
Reviews of qualitative studies that examine how or why
interventions work and/or reviews of observational studies
Characterizing stakeholders’ views about and experiences
with the policy options
Reviews of qualitative studies that examine stakeholders’ views
about and experiences with particular options
Identifying
implementation
considerations
Identifying potential barriers to implementation at the level of
patients/consumers, health workers, organizations, and systems
Reviews of observational studies and/or reviews of qualitative
studies
Characterizing the effects of appropriately targeted
implementation strategies
Reviews of effectiveness studies
doi:10.1371/journal.pmed.1000141.t001
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Type Goal Examples
Sponsor/Initiative Systematic Reviews Included
Summaries
of systematic
reviews
Summarize systematic reviews in order to: (1) allow policymakers to identify
the take-home messages from systematic reviews that address their policy
question (or elements of their policy question); and (2) (occasionally) add
value to a review by evaluating its quality, grading the strength of evidence
contained in it, identifying local applicability and equity considerations, and/
or providing commentaries by select users of the reviews
ACC Policy Liaison
Initiative
Reviews of policy-relevant reviews, which
are typically health system interventions,
provider behaviour-change interventions,
and consumer-targeted reviews [29]
DARE Reviews of the effects of health or health-
system interventions
Effective Health Care
Research Programme
Consortium
Same as ACC but with a particular focus
on LMICs
Evidence Aid Same as DARE but with a particular focus
on natural disasters and other health care
emergencies (originally done in response
to the 2004 tsunami and now updated in
response to the H1N1 pandemic) [30]
Health Knowledge
Network of the CC&CRG
Evidence Bulletins
Reviews of the effects of consumer-
targeted reviews
Health-evidence.ca Reviews of the effects of public-health
interventions
Reproductive Health
Library
Reviews of the effects of reproductive-
health interventions, with a particular
focus on LMICs
Rx for Change Reviewsoftheeffectsofprescribing-related
interventions (and provider behaviour-
change interventions more generally)
SUPPORT Same as ACC but with a particular focus
on LMICs
Overviews of
systematic
reviews
Systematically and transparently identify, select, appraise, and synthesize
systematic reviews that address the broad array of research questions in
a given domain in order to: (1) allow policymakers to identify systematic
reviews that address their policy question (or elements of their policy
question) and the take-home messages from these reviews; (2) allow
policymakers to identify gaps in coverage by existing systematic reviews
that will need to be filled through policymakers’ own efforts to review
research studies or through systematic reviews that they commission
IDEAHealth Reviews of the effects of health system
financing mechanisms [31], human
resource interventions, [32,33], and
interventions to reduce maternal and
child mortality [34,35], with a particular
focus on LMICs
SUPPORT Reviews of the effects of interventions to
support the delivery of cost-effective
interventions in health systems and in
maternal and child health, with a
particular focus on LMICs [36]
Cochrane Collaboration’s
EPOC review group
Reviews of the effects of provider
behaviour-change interventions [37]
Cochrane Collaboration’s
CC&CRG review group
Protocol for a review of the effects of
consumer-targeted interventions [38]
Policy briefs Systematically and transparently identify, select, appraise, and synthesize
systematic reviews, research studies, and context-specific data in order to
address all elements of a policy question in order to: (1) allow policymakers
to define the underlying problem, characterize policy and program options
to address the problem, and identify implementation considerations; (2)
allow policymakers to identify gaps in coverage by existing systematic
reviews, studies, and context-specific data that will need to be filled
Health Evidence Network/
European Observatory on
Health Systems and Policies
Reviews that inform problem definition,
policy option characterization, and policy
implementation-strategy characterization
at the regional level, with a particular
focus on the European Region
EVIPNet Reviews that inform problem definition,
policy option characterization, and policy
implementation-strategy characterization
at the country level, with a particular focus
on countries in Africa, Asia, and the
Americas with formally established
evidence-to-policy partnerships (EVIPNet)
ACC, Australasian Cochrane Centre; CC&CRG, Cochrane Consumers and Communication; DARE, Database of Abstracts of Reviews of Effects; EPOC, Effective Practice and
Organization of Care; EVIPNet, Evidence-Informed Policy Networks; IDEAHealth, International Dialogue on Evidence-Informed Action to Achieve Health Goals in
Developing Countries; LMICs, low- and middle-income countries; SUPPORT, Supporting Policy Relevant Reviews and Trials.
doi:10.1371/journal.pmed.1000141.t002
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policy or program options to address the
problem, and possible implementation
strategies for these options (Table 2). Some
summaries add significant value to a
review by highlighting key findings, eval-
uating the review’s quality [18,19], grad-
ing the strength of evidence contained in it
[20], identifying local applicability and
equity considerations [21–23], and/or
providing commentaries by select users of
the reviews. Identifying local applicability
considerations is particularly important for
reviews that address governance, financial,
and delivery arrangements in health
systems because the lessons learned from
these reviews are likely to be context-
sensitive [1,24]. One key challenge lying
ahead will be to ensure that summary-
production processes keep up with the
review-production/updating processes,
Table 3. Examples of activities to support the use of systematic reviews and review-derived products by policymakers and
stakeholders.
Approach Examples of Activities
Promoting a climate that supports the use of reviews
and review-derived products in policymaking processes
Citing examples from the past or from other jurisdictions where the use of reviews made the difference
between policy success and policy failure
Conducting an audit of policy documents to identify whether and how existing systematic reviews were
cited
Modifying policymaking processes to give an explicit role for systematic reviews, however, this is likely
possible only for ‘‘routine’’ decisions like coverage decisions about prescription drugs and other
‘‘technologies’’ [39,40]
Producing reviews and review-derived products that
address high-priority policy issues
Undertaking priority-setting processes that identify short term (1–6 mo) requirements for review-derived
products, medium-term (6–18 mo) requirements for systematic reviews, and long-term (.18 mo)
requirements for primary research [41]
Engaging policymakers and stakeholders in the production of reviews and review-derived products [42]
Engaging policymakers and stakeholders in the ‘‘merit review’’ of reviews and review-derived products
Packaging reviews and review-derived products for
policymakers and stakeholders
Wording the title in a way that would engage policymakers and stakeholders (e.g., as a question, with a
solution-orientation)
Presenting findings using an ‘‘inverted pyramid’’ (e.g., bulleted key messages, executive summary, full
report)
Highlighting the take-home messages from the review, particularly decision-relevant information (e.g.,
benefits and harms of policy options)
Highlighting the contexts in which the included studies were conducted that might influence
assessments of local applicability
Highlighting the characteristics of the participants in the included studies and the contexts in which the
studies were conducted that might raise equity considerations
Using a format that is consistent, visually interesting (e.g., a mix of colours and of bulleted text, figures,
and tables), and ‘‘skimmable’’
Using language that is appropriate to policymakers and stakeholders, with technical language restricted
to an appendix
Disseminating reviews and review-derived products to
policymakers and stakeholders
Providing an option to sign up for an e-mail alert when new reviews or review-derived products are
posted online
Sending a ‘‘refresher’’ e-mail alert about a review or review-derived product when a ‘‘window of
opportunity’’ opens
Engaging policymakers and stakeholders in providing online commentaries about specific reviews or
review-derived products
Providing online briefings (e.g., webinars) about specific reviews or review-derived products
Providing face-to-face briefings about specific reviews or review-derived products
Giving presentations at meetings about specific reviews or review-derived products coupled with
policymaker commentaries
Executing proactive knowledge-translation strategies (e.g., identifying key messages, determining the
principal target audiences for each of these messages, seeking out the most credible messenger for these
messages and engaging their interest in becoming involved in the communication of these messages,
and supporting their communication efforts) [43]
Providing policymakers and stakeholders with the resources,
skills, and opportunities to find and use reviews and review-
derived products when they need them
Making reviews and review-derived products available through policymaker-targeted, searchable
databases [44] (e.g., PPD/CCNC database for health system-targeted interventions, Rx for Change
database for clinician-targeted interventions, and Resource Bank for consumer-targeted interventions)
Providing policymakers and stakeholders with training so that they can find and use reviews and review-
derived products and understand their value relative to other sources of research evidence [45]
Organizing ‘‘deliberative dialogues’’ at which the knowledge arising from systematic reviews can be
combined with the tacit (i.e., how to) knowledge and other types of knowledge brought forward by
participating policymakers and stakeholders (e.g., about on-the-ground realities and constraints, citizens’
values and beliefs, interest group power dynamics, and institutional constraints) [6–8]
PPD, Program in Policy Decision-Making; CCNC, Canadian Cochrane Network and Centre.
doi:10.1371/journal.pmed.1000141.t003
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whether and when an apparent duplica-
tion of effort in the production of these
summaries at the international level is
problematic, and not simply the result of
experimentation or appropriate targeting
to particular audiences and contexts.
Overviews of systematic reviews can
add value in some of the same ways as
summaries of systematic reviews, albeit
with a greater emphasis on breadth of
coverage (e.g., the range of policy and
program options examined) than depth of
coverage (e.g., detail about what is known
about any one option). Policy briefs, on the
other hand, start with a policy issue, not
with the reviews that researchers happen
to have produced. The few current
producers of policy briefs (as we have
defined them in Table 2) have differed in
their jurisdictional focus (e.g., whether the
effort to contextualize the research evi-
dence focuses on a country or a whole
region) and in whether the briefs are seen
as an end in themselves or as an input to
one or more ‘‘deliberative dialogues.’’
Such dialogues typically involve convening
one to two dozen policymakers and
stakeholders to work through a policy
issue, drawing on both the policy brief and
their own and others’ tacit knowledge
about the issue.
Activities That Could Support
the Use of Systematic Reviews
A range of activities are being piloted to
support the use of reviews and review-
derived products in policymaking (Table 3)
[25,26]. Few evaluations of the effective-
ness of these activities have been under-
taken; however, a group led by researchers
at the Melbourne School of Population
Health is registering a title for a systematic
review on this topic with the Cochrane
Collaboration. All that is available to
inform decisions about the relative em-
phasis to give to these options are
systematic reviews of the factors that
influence the use of research evidence in
policymaking [2,27,28]. A small number
of factors emerged in these reviews with
some frequency:
N Interactions between researchers and
policymakers increased (and a lack of
interactions decreased) the prospects
for using research evidence, particu-
larly when the interactions were based
on informal relationships;
N Timeliness increased (and a lack of
timeliness decreased) the prospects for
research use; and
N Accordance between research evi-
dence and the beliefs, values, interests
or political goals, and strategies of
policymakers and stakeholders (or
when political positions had not yet
been taken) increased (and discor-
dance decreased) the prospects for
using research evidence.
The importance of interactions under-
pins efforts by some organizations to
engage both researchers and policymakers
in priority-setting and/or production ac-
tivities and in deliberative dialogues. The
importance of timeliness underpins efforts
to create and continuously update data-
bases that provide ‘‘one stop shopping’’ for
optimally packaged reviews and review-
derived products, as well as efforts to
develop capacity among policymakers to
find and use research evidence efficiently
(which includes improving their under-
standing of how many types of systematic
reviews are needed to inform any given
policymaking process and raising their
awareness about the sources of these
reviews and review-derived products).
The importance of an accordance between
research evidence and policymakers’ be-
liefs, values, interests or political goals, and
strategies underpins efforts to identify
‘‘windows of opportunity’’ in policymaking
processes and use review-derived products
as the basis for engaging policymakers and
the stakeholders seeking to influence them,
as well as efforts to support the ‘‘real time’’
identification of an accordance (e.g.,
through well-facilitated deliberative dia-
logues). However, all of these activities
warrant evaluation and, if found to be
effective, scaling-up in order to support the
use of reviews and review-derived prod-
ucts by all policymakers and stakeholders.
Conclusion
Supporting the use of systematic reviews
in policymaking has received growing
attention in recent years. More of the
types of reviews needed by policymakers
and stakeholders are being produced,
which reduces the burden placed on
policymakers and stakeholders to find
and synthesize the research evidence on
their own. Similarly, more review-derived
products targeted at policymakers and
stakeholders are being produced, and
these products increasingly help to address
the unique challenges faced by these
groups, namely assessing the local appli-
cability of reviews and mobilizing the
range of reviews that are needed in
different steps in the policymaking process.
Finally, many activities to support the use
of reviews are being piloted. Future
challenges include working through
whether and when an apparent duplica-
tion of effort in the production of these
summaries is problematic and scaling up
activities that are found to be effective in
supporting the use of reviews and review-
derived products.
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